Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.9%

2 terminated out of 29 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

13%

2 of 16 completed with results

Key Signals

2 with results89% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (17)
Early P 1 (1)
P 1 (4)
P 2 (2)

Trial Status

Completed16
Recruiting5
Not Yet Recruiting3
Terminated2
Unknown1
Withdrawn1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT05722210Not Yet RecruitingPrimary

Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant

NCT06575712Not ApplicableRecruitingPrimary

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

NCT06496477Not ApplicableNot Yet RecruitingPrimary

Light Therapy to Treat Depression in Pediatric Stem Cell Therapy Recipients

NCT03613532Phase 1Active Not Recruiting

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

NCT06328127Not ApplicableRecruitingPrimary

Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

NCT04263597Phase 1CompletedPrimary

Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients

NCT02982902Early Phase 1Recruiting

T Cell Therapy of Opportunistic Cytomegalovirus Infection

NCT05945121Not ApplicableRecruitingPrimary

Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT06462365Phase 1Recruiting

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

NCT06792630Not ApplicableNot Yet Recruiting

A Study of the Effect of Laughter Therapy on the Mental Health and Quality of Survival of Hematopoietic Stem Cell Transplant Patients

NCT06692478Not ApplicableCompletedPrimary

Benefits of Intrahospital Exercise Program in Pediatric HSCT

NCT04118530CompletedPrimary

Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant

NCT03759262Phase 1CompletedPrimary

Ultra-high Dose Vitamin D for HSCT

NCT04853277Not ApplicableCompleted

Patient Reported Outcomes and Patient Education in Cellular Therapy Patients

NCT03886909Not ApplicableCompletedPrimary

Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant

NCT03202849Not ApplicableCompletedPrimary

A Randomized Trial of Vitamin D Supplementation With or Without Vitamin A in Stem Cell Transplantation

NCT04549038Not ApplicableCompletedPrimary

Time Restricted Nutrition in Pediatric Stem Cell Transplant Recipients

NCT03509051Not ApplicableCompletedPrimary

Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation

NCT03737084Not ApplicableCompletedPrimary

Effects of Compassion Training to Patients Undergoing HSCT on Biological and Psychosocial Parameters

NCT03378089Not ApplicableCompletedPrimary

Music Therapy and Hematopoietic Stem Cell Transplant

Scroll to load more

Research Network

Activity Timeline